July 22, 2021
Breakthrough T1D x Beyond Type 1 Alliance Offers Type 1 Diabetes Community First-Ever Spanish-Language TypeOneNation Summit
July 20, 2021
Breakthrough T1D and the Association of Diabetes Care & Education Specialists Announce New Partnership
July 9, 2021
Breakthrough T1D Statement: Biden Administration Executive Order on Promoting Competition in the American Economy and Lower Drug Prices
July 6, 2021
Breakthrough T1D Statement on FDA Complete Response Letter for Teplizumab
June 29, 2021
Breakthrough T1D Official Statement on the Launch of Walmart’s Low-Cost Insulin Brand
June 17, 2021
Breakthrough T1D Statement on the U.S. Supreme Court Affordable Care Act Ruling
June 10, 2021
Statement from Breakthrough T1D Vice President of Research, Sanjoy Dutta, Ph.D., on the appointment of Kevan Herold, M.D., to TrialNet Chair
June 2, 2021
Breakthrough T1D Chair Premier Panel at 2021 Advanced Technologies & Treatments for Diabetes Conference Featuring Provention Bio, ViaCyte and vTv Therapeutics
May 27, 2021
Breakthrough T1D Statement on FDA Advisory Committee Recommendation of Teplizumab
May 20, 2021
Breakthrough T1D Celebrates Global Accessibility Awareness Day Spotlighting Accessibility Features to Breakthrough T1D.org
